Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 9:55 pm Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | ARMISTICE CAPITAL LLC | 0 0.000% | -2,742,000 (Position Closed) | Filing History |
| 2022-02-11 7:47 pm Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Stonepine Capital Management LLC | 0 0.000% | -3,408,849 (Position Closed) | Filing History |
| 2022-01-26 11:00 am Sale | 2021-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Opaleye Management Inc. | 0 0.000% | -1,487,800 (Position Closed) | Filing History |
| 2021-12-10 08:52 am Sale | 2021-12-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS | FMR LLC | 0 0.000% | -4,575,536 (Position Closed) | Filing History |
| 2021-10-20 3:42 pm Sale | 2021-10-11 | 13G | Adamas Pharmaceuticals, Inc. ADMS | HIRSCHMAN ORIN | 0 0.000% | -1,611,313 (Position Closed) | Filing History |
| 2021-10-19 4:26 pm Purchase | 2021-10-11 | 13D | Adamas Pharmaceuticals, Inc. ADMS | Magnetar Financial LLC | 3,131,937 6.850% | 3,131,937 (New Position) | Filing History |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Adamas Pharmaceuticals, Inc. ADMS | FMR LLC | 4,575,536 11.060% | 4,251,667 (+1312.77%) | Filing History |
| 2021-03-01 6:06 pm Purchase | 2021-02-25 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Stonepine Capital Management LLC | 3,408,849 7.600% | 2,600,418 (+321.66%) | Filing History |
| 2021-02-22 07:18 am Purchase | 2021-02-16 | 13G | Adamas Pharmaceuticals, Inc. ADMS | HIRSCHMAN ORIN | 1,611,313 11.000% | 1,611,313 (New Position) | Filing History |
| 2021-02-16 2:47 pm Purchase | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | ARMISTICE CAPITAL LLC | 2,742,000 9.600% | 546,000 (+24.86%) | Filing History |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Opaleye Management Inc. | 1,487,800 5.220% | 61,800 (+4.33%) | Filing History |
| 2021-02-12 4:48 pm Sale | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Stonepine Capital Management LLC | 808,431 2.800% | -1,432,808 (-63.93%) | Filing History |
| 2021-02-12 08:23 am Sale | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | MACQUARIE GROUP LTD | 0 0.000% | -2,167,416 (Position Closed) | Filing History |
| 2020-08-21 5:15 pm Purchase | 2020-08-11 | 13G | Adamas Pharmaceuticals, Inc. ADMS | Opaleye Management Inc. | 1,426,000 5.040% | 1,426,000 (New Position) | Filing History |
| 2020-07-10 10:39 am Sale | 2020-06-30 | 13G | Adamas Pharmaceuticals, Inc. ADMS | BlackRock Inc. BLK | 598,070 2.100% | -1,137,239 (-65.54%) | Filing History |